1. Home
  2. Search

Search

Search results

230 results found

Contact

Page
Thomas E. Scammell, MD Dept. of Neurology, Beth Israel Deaconess Medical Center 330 Brookline Avenue, Boston 02215, USA email: tscammel@bidmc.harvard.edu phone: 617-735-3260 Full PubMed Bibliography: https://pubmed.ncbi.nlm.nih.gov/?term=Scammell+TE&cauthor_id=28231463

15] Facts About: UDP-Glucuronic Acid and Glucuronosyltransferases in the ER

Blog: January 13, 2025
By: Richard D. Cummings The endoplasmic reticulum (ER) of many types of cells contain members of a family of UDP-glucuronosyltransferases (UGTs). These enzymes utilize uridine diphosphate glucuronic acid (UDP-GlcA) as a donor and add GlcA to a tremendous variety of aglycone hydrophobic compounds...

Ava Homiar

she/her
Person: Research Assistant
Ava Homiar is a Research Assistant in the Division of Clinical Informatics at Beth Israel Deaconess Medical Center. Her research focuses on evaluating the clinical utility of AI and digital technology for the monitoring and treatment of symptoms in individuals living with mental illness, as well as...

New Research Assistant Joins the Lab!

News: September 16, 2024
This September we were joined by our new RA, Jane! Jane joined the lab after completing her undergraduate studies at Muhlenberg College with degrees in Neuroscience and Philosophy. She is excited to bring her passion for scientific inquiry to the lab. Welcome, Jane!

REDCap Upgrade

News: January 06, 2025
The newest upgrade of REDCap at BILH has great features for all REDCap users, project designers in particular. This includes: New icons in the online designer Bulk editing of fields in the online designer Bulk move of fields in the online designer Split matrix into separate fields / create matrix...

Andrew Gumbert

Person:
Andrew Gumbert is an MSc candidate at Harvard Medical School in the Biomedical Informatics program. In the Benitez lab, Andrew works as a research student who is interested in applying computational methods to find relationships between omic data and neurodegenerative diseases. Andrew hopes to...